Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
Impact of Hospital Consolidation on Outcomes, Quality, and Access
Testimony: Delivered to Pennsylvania House of Representatives Subcommittee on Health Facilities
Print:
On October 4, 2023, University of Pennsylvania Leonard Davis Institute of Health Economics (LDI) Executive Director Rachel M. Werner, MD, PhD, testified at the Pennsylvania House of Representatives Subcommittee on Health Facilities about the impact widespread hospital consolidations are having on the financial outcomes, quality, and access to care throughout the U.S. healthcare system. In her presentation, she summarized the evidence that consolidation increases commercial healthcare prices, with no positive effects on quality and potential deleterious effects on access.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Projected Mortality Impacts of the Budget Reconciliation Bill
Research Memo: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Research Memo: Supplement to Response to Request for Technical Assistance
Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Research Memo: Delivered to Staff of U.S. Senate Committee on Finance